Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | fenbendazole | 10237 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | fenbendazole | 10237 | drug-path |
| Shigellosis | 0 | map05131 | fenbendazole | 10237 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | fenbendazole | 10237 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | fenbendazole | 10237 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | fenbendazole | 10237 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | fenbendazole | 10237 | drug-path |
| Thyroid cancer | R-HSA-9700206 | map05216 | fenbendazole | 10237 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | fenbendazole | 10237 | drug-path |
| Non-homologous end-joining | R-HSA-5693571 | map03450 | fenbendazole | 10237 | drug-path |
| Non-small cell lung cancer | R-HSA-5619066 | map05223 | fenbendazole | 10237 | drug-path |
| Endometrial cancer | R-HSA-2077421 | map05213 | fenbendazole | 10237 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | fenbendazole | 10237 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | fenbendazole | 10237 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | 2,6-dimethylpiperidine | 19009 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | 2,6-dimethylpiperidine | 19009 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | 2,6-dimethylpiperidine | 19009 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | 2,6-dimethylpiperidine | 19009 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | 2,6-dimethylpiperidine | 19009 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | 2,6-dimethylpiperidine | 19009 | drug-path |